首页> 外文期刊>Science >Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
【24h】

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer

机译:TMPRSS2和ETS转录因子基因在前列腺癌中的复发融合

获取原文
获取原文并翻译 | 示例
       

摘要

Recurrent chromosomal rearrangements have not been well characterized in common carcinomas. We used a bioinformatics approach to discover candidate oncogenic chromosomal aberrations on the basis of outlier gene expression. Two ETS transcription factors, ERG and ETV1, were identified as outliers in prostate cancer. We identified recurrent gene fusions of the 5' untranslated region of TMPRSS2 to ERG or ETV1 in prostate cancer tissues with outlier expression. By using fluorescence in situ hybridization, we demonstrated that 23 of 29 prostate cancer samples harbor rearrangements in ERG or ETV1. Cell line experiments suggest that the androgen-responsive promoter elements of TMPRSS2 mediate the overexpression of ETS family members in prostate cancer. These results have implications in the development of carcinomas and the molecular diagnosis and treatment of prostate cancer.
机译:复发性染色体重排在常见癌中尚未得到很好的表征。我们使用生物信息学方法在异常基因表达的基础上发现候选致癌染色体畸变。两种ETS转录因子ERG和ETV1被确定为前列腺癌的异常值。我们确定了前列腺癌组织中TMPRSS2的5'非翻译区对ERG或ETV1的复发性基因融合与异常表达。通过使用荧光原位杂交,我们证明了29个前列腺癌样本中的23个在ERG或ETV1中具有重排。细胞系实验表明,TMPRSS2的雄激素响应性启动子元件介导了前列腺癌中ETS家族成员的过度表达。这些结果对癌症的发展以及前列腺癌的分子诊断和治疗有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号